Issued Patents All Time
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10357514 | Treatment of cancer using anti-CD19 Chimeric Antigen Receptor | Carl H. June, David L. Porter, Marcela Maus, Saar Gill, Joseph A. Fraietta +11 more | 2019-07-23 |
| 10166251 | STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinases | Qian Zhang | 2019-01-01 |
| 9486469 | STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinases | Qian Zhang | 2016-11-08 |
| 9255279 | Anaplastic lymphoma kinase (ALK) as an oncogene capable of transforming normal human cells | James L. Riley, Qian Zhang, Fang Wei | 2016-02-09 |
| 8778961 | O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders | Leslie M. Shaw | 2014-07-15 |
| 8759370 | O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders | Leslie M. Shaw | 2014-06-24 |
| 8569332 | O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders | Leslie M. Shaw | 2013-10-29 |
| 7781447 | O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders | Leslie M. Shaw | 2010-08-24 |
| 7754734 | O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders | Leslie M. Shaw | 2010-07-13 |